The Big News: FDA Ends Ozempic & Wegovy Shortage

On February 21, 2025, the U.S. Food and Drug Administration (FDA) made a major announcement: the semaglutide shortage is officially resolved. For patients across New Jersey, New York, and Philadelphia, this means Ozempic and Wegovy should once again be available through traditional retail pharmacies.

But with the headlines came confusion. Many patients still report long waits, unclear pharmacy inventory notices, and insurance denials. Plus, the FDA’s announcement also impacts the availability of compounded GLP-1 copycats—which were permitted only while commercial products were backordered.

So, what does this all mean for your weight-loss journey? Let’s break it down.

What Does “Shortage Resolved” Really Mean?

While the FDA has removed semaglutide from its drug shortage database, that doesn’t necessarily mean instant stock at your local pharmacy. Here’s how to interpret the news:

✅ What It Does Mean:

• Manufacturers have restored consistent supply at the national level.
• Pharmacies can now reliably order Wegovy and Ozempic from wholesalers.
• The legal window for compounded versions is closing—they were only allowed during shortages.

⚠️ What It Doesn’t Mean:

• Your local pharmacy will have doses on the shelf immediately.
• Insurance coverage or out-of-pocket costs have improved (yet).Backlogged prior authorizations or new prescriptions will process faster by default.

Tip:

At Al Excellence Pharmacy, we’re already seeing reliable weekly shipments of GLP-1 products, and our free delivery services help patients across NJ get access without the extra hassle. If you’re unsure about timing or stock, call or email us for availability updates.

Why Is My Prescription Still Delayed?

Despite the FDA’s update, here are some reasons patients may still face hiccups:

🧾 1. Insurance Prior Authorization (PA) Delays

Now that compounded alternatives are being phased out, many patients are switching to brand-name versions—prompting new PA requirements.

💡 Tip: Strong prior-auths include:

✓ Full diagnosis with BMI and comorbidities

✓ History of failed weight-loss treatments

✓ A note indicating the FDA-approved brand (Wegovy or Ozempic) 

💬 Our pharmacists are here to help you and your provider prepare the right documentation—just reach out.

🏷 2. “Brand-Only” Prescriptions

Some providers are now explicitly writing “brand only” due to FDA safety concerns with compounded products. This can delay processing if pharmacies try to substitute or use a generic code.

Provider Tip: Specify the NDC (National Drug Code) of the preferred GLP-1 brand to avoid pharmacy confusion.

Will Compounded Semaglutide Still Be Available?

⚖️ Not For Long.

While some compounding pharmacies may still offer semaglutide injections, the FDA has signaled a coming crackdown now that official supply is restored. Expect:

• Fewer options for compounded GLP-1s
• Payers rejecting claims for non-branded versions
• Legal enforcement against unauthorized production

If you’re currently using a compounded version:

• Check with your prescriber about switching to a commercial product
• Call Al Excellence Pharmacy to discuss your transition—we can help coordinate with your provider

How to Refill GLP-1 Injections With Confidence

Here’s a quick refill readiness checklist for patients who are switching or resuming treatment:

📋 Refill Checklist Infographic: (Insert visual infographic with the following items visually marked off)

✔ Confirm your pharmacy’s current stock

✔ Verify your insurance coverage and PA status

✔ Ask about manufacturer coupons or savings cards

✔ Confirm the dose your provider prescribed

✔ Plan for side effect management during titration

✔ Schedule a follow-up appointment within 4–6 weeks

💬 Need help? Our team at Al Excellence Pharmacy can walk you through each step—just give us a call.

We’re Here to Help: Al Excellence Pharmacy Support

Whether you’re new to GLP-1 therapy or navigating a post-shortage refill, our team is here to guide you with:

• 📦 Home delivery in NJ
• 📄 Prior auth support for patients and providers
• 💬 Side effect counseling and titration tips
• 📲 One-on-one help reviewing manufacturer savings options

Final Word

The FDA’s “out-of-shortage” declaration for GLP-1s like Wegovy and Ozempic is good news—but access is still a process. Patients should expect a transitional period, especially if switching from compounded alternatives or navigating new prior-auth requirements.

📞 Need help filling your GLP-1 prescription? Contact Al Excellence Pharmacy today or visit alexcellencepharmacy.com to check stock, get delivery options, and connect with our expert pharmacy team.